Chemoinformaics analysis of Butyl butyryllactate
| Molecular Weight | 216.277 | nRot | 7 |
| Heavy Atom Molecular Weight | 196.117 | nRig | 2 |
| Exact Molecular Weight | 216.136 | nRing | 0 |
| Solubility: LogS | -2.22 | nHRing | 0 |
| Solubility: LogP | 2.775 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 34.9139 |
| nHD | 0 | BPOL | 25.2721 |
| QED | 0.483 |
| Synth | 2.433 |
| Natural Product Likeliness | -0.143 |
| NR-PPAR-gamma | 0.041 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.953 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.424 |
| MDCK | 0.000043 |
| BBB | 0.969 |
| PPB | 0.608766 |
| VDSS | 0.777 |
| FU | 0.528018 |
| CYP1A2-inh | 0.912 |
| CYP1A2-sub | 0.294 |
| CYP2c19-inh | 0.696 |
| CYP2c19-sub | 0.67 |
| CYP2c9-inh | 0.206 |
| CYP2c9-sub | 0.468 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.149 |
| CYP3a4-inh | 0.06 |
| CYP3a4-sub | 0.249 |
| CL | 9.012 |
| T12 | 0.851 |
| hERG | 0.027 |
| Ames | 0.009 |
| ROA | 0.011 |
| SkinSen | 0.927 |
| Carcinogencity | 0.075 |
| EI | 0.961 |
| Respiratory | 0.071 |
| NR-Aromatase | 0.216 |
| Antiviral | No |
| Prediction | 0.573379 |